Dr. Gopalakrishnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
345 Blackstone Blvd
Providence, RI 02906Phone+1 401-455-6669Fax+1 401-455-6670
Summary
- I am board certified Neurologist and Movement Disorder specialist,
Movement Disorders Program , and Memory and aging Program , Butler hospital,
Clinical Assistant professor, Department of Neurology, Brown University, Warren-Alpert School of Medicine, Providence, RI.
Attending Neurologist , Rhode Island Free clinic, Providence, RI.
Before practicing in the USA, I have worked in India and in UAE as neurologist .
Education & Training
- University of ConnecticutResidency, Neurology, 2017 - 2021
- University of British columbiaFellowship in Movement disorders, 2008 - 2010
- NIMHANSDM Neurology, 2002 - 2005
- NHL municipal medical collegeMD Internal medicine, 1998 - 2001
- University of Kerala Medical CollegeClass of 1995
Certifications & Licensure
- RI State Medical License 2020 - 2026
- CT State Medical License 2017 - 2021
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- fastest IV t PA treatment for acute stroke patients Hartford hospital /UCONN neurology department, 2019-2020
Publications & Presentations
PubMed
- 1 citationsDopamine Transporter Scan (DAT) in Parkinsonism - a Short Review for Non-Neurologists.Biju Gopalakrishnan, Joseph H Friedman
Rhode Island Medical Journal. 2023-09-01 - Klinefelter's Syndrome with Tremors, Ataxia and Parkinsonism.Biju Gopalakrishnan, Joseph H Friedman
Rhode Island Medical Journal. 2023-04-03 - Isolated Toe Tremor Associated with Antiphospholipid Syndrome.Biju Gopalakrishnan, Joseph H Friedman
Rhode Island Medical Journal. 2024-06-03
Journal Articles
- Atypical Parkinsonism-A Mini Review for Non-NeurologistsGopalakrishnan B, . Sys Rev Pharm, 2023
- Thirty-day readmissions in multiple sclerosis: An age and gender-based US national retrospective analysis. Patel S, SirDeshpande P, Desai R, Desai N, Mistry H, Patel N, Mansuri Z, Gopalkrishnan B, Mehta T, Mahuwala Z, Narwal P, Garg N, Mult Scler Relat Disord, 6/2019
- Reversible “Pulvinar” sign in Wernicke’s encephalopathyGopalakrishnan B, Ashraf V, Kumar P, Kiran K, Ann Indian Acad Neurol, 4/17/2014
- Join now to see all
Books/Book Chapters
Research History
- Sub -Investigator1.A4: Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study). 2.LEARN: 18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study 3.ADNI 3: Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) 4.AHEAD 3-45 5.DIAN Observational 6.DIAN TU 7.Biogen Embark 8.Jans
Professional Memberships
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: